Robert W. Herring

Statistics

Publications

Citations

421

H-Index

Active since

2014

Affiliations

Texas Liver Institute(Current)

Quality Research

Johns Hopkins University

Johns Hopkins Medicine

Gilead Sciences (United States)

Robert W. Herring is an author at Texas Liver Institute specializing in sustained virologic response duration, hepatitis pharmacotherapy, and infectious diseases.

Publications per year

2014–2015

Publications

Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus

Eric M. Yoshida, Mark Sulkowski, Edward Gane et al. · Hepatology · 2014 · 196 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)

Eric Lawitz, Gary Matusow, Edwin DeJesus et al. · Hepatology · 2015 · 180 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

All-Oral Combination of Ledipasvir, Vedroprevir, Tegobuvir, and Ribavirin in Treatment-Naïve Patients With Genotype 1 HCV Infection

David Wyles, M. Rodríguez‐Torres, Eric Lawitz et al. · Hepatology · 2014 · 45 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–3 of 3